The Goldman Sachs Group Increases CVS Health (NYSE:CVS) Price Target to $97.00

CVS Health (NYSE:CVS) had its price target increased by research analysts at The Goldman Sachs Group from $95.00 to $97.00 in a report released on Thursday,MarketScreener reports. The firm currently has a “buy” rating on the pharmacy operator’s stock. The Goldman Sachs Group’s price target suggests a potential upside of 23.65% from the stock’s current price.

CVS has been the topic of a number of other research reports. Truist Financial set a $100.00 target price on CVS Health in a research note on Wednesday, December 10th. Sanford C. Bernstein reiterated a “market perform” rating and set a $91.00 price objective on shares of CVS Health in a research report on Tuesday, January 6th. Piper Sandler reissued an “overweight” rating and set a $101.00 price objective (up from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Barclays lifted their price target on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Price Performance

CVS Health stock opened at $78.45 on Thursday. The stock has a market cap of $99.80 billion, a price-to-earnings ratio of 56.85, a PEG ratio of 0.81 and a beta of 0.50. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The business has a 50-day simple moving average of $78.64 and a 200 day simple moving average of $76.13. CVS Health has a 52 week low of $58.35 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company’s revenue was up 8.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, research analysts forecast that CVS Health will post 5.89 earnings per share for the current fiscal year.

Hedge Funds Weigh In On CVS Health

A number of hedge funds have recently modified their holdings of the company. SOA Wealth Advisors LLC. grew its stake in shares of CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 131 shares during the last quarter. Alteri Wealth LLC grew its position in shares of CVS Health by 3.2% in the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock worth $316,000 after buying an additional 131 shares during the last quarter. TOWER TRUST & INVESTMENT Co increased its stake in shares of CVS Health by 0.8% during the fourth quarter. TOWER TRUST & INVESTMENT Co now owns 15,708 shares of the pharmacy operator’s stock valued at $1,247,000 after buying an additional 132 shares during the period. Holistic Financial Partners lifted its stake in CVS Health by 4.1% in the third quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock worth $256,000 after acquiring an additional 133 shares during the period. Finally, CYBER HORNET ETFs LLC boosted its holdings in CVS Health by 4.1% in the third quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock valued at $259,000 after acquiring an additional 134 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.